Certificate of Analysis
| Product Name: | Terazosin hydrochloride dihydrate |
| Catalog Number: | M5999 |
| CAS Number: | 70024-40-7 |
Physical and Chemical Properties
| Formula: | C19H25N5O4.HCl.2(H2O) |
| Molecular Weight: | 459.92 |
| Solubility: | DMSO 26 mg/mL; Water 10 mg/mL |
| Storage: | 4°C, dry, sealed |
| Chemical Structure: |  |
Analytical Data
| QC Standard: | >99.0% |
| H-NMR: | Consistent with structure |
Product Information
| Description: | Terazosin hydrochloride dihydrate is a selective, competitive and orally active α1-adrenoceptor antagonist. Terazosin is also an agonist of HSP90. Terazosin hydrochloride dihydrate can be used for the research of benign prostatic hyperplasia (BPH) and high blood pressure. |
| Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |